Skip to content

Health & Science

Public health, medical research, scientific evidence and health systems.

Evidence analysis

Human medicines European public assessment report (EPAR): Flixabi, infliximab, Date of authorisation: 26/05/2016, Revision: 31, Status: Authorised

What is established Flixabi is a biosimilar medicine containing infliximab, a monoclonal antibody targeting tumour necrosis factor-alpha (TNF-alpha), an inflammatory protein elevated in conditions such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and psoriasis.…

Read →

Evidence analysis

Rethinking psychosocial rehabilitation in mental health

Rethinking Psychosocial Rehabilitation in Mental Health: An Evidence Overview This evidence dossier summarizes key findings and considerations from a 2026 article published in PLOS Medicine that addresses psychosocial rehabilitation in mental health care. It reviews the current state,…

Read →